Getting it right the first time

Article Abstract:

The first few decisions biotech industrialists makes when forming a company can make a difference after a few years but some careful planning can smooth the way for later success. Founders need to keep one eye firmly on the future when deciding what type of business entity to form and how to allocate equity in that entity, the decision that can either lay a sold foundation for the business or set up a house of cards.

Businesspeople, Entrepreneurship, Entrepreneurs

---

Abe Abuchowski

Article Abstract:

A brief note on Abe Abuchowski, the CEO of one of the first companies to make protein delivery into profitable business by patenting a technique for poly(ethylene gylcol) is presented. Although his technology, PEGylation is considered an industry gold standard, its three-decade development history illustrates the often rocky path to commercial success for platforms.

Science & research, Research, Beliefs, opinions and attitudes, Abuchowski, Abe

---

Elliot Entis

Article Abstract:

Elliot Entis, CEO and cofounder of Aqua Bounty Technologies (ABT), describes his success in the seafood industry and the way he attracted investor through public offerings. His experiences in gaining success in animal biotech shows that endurance is key in bringing pioneering technologies to market.

Securities issued, listed, Securities, Company securities, Entis, Elliot

Similar abstracts:

• Abstracts: The man with the money. Sleep easy. Return of the suit
• Abstracts: Billion pound boost for Top 60 firms. The year of uncertainty. Listen to investors for a thriving audit market
• Abstracts: Think FRSSE first. Safe harbour in sight? The way forward
• Abstracts: Employment taxes update. An old wives' tale
• Abstracts: Ethical behaviour. The art of affairs. Open justice (if you don't mind waiting)

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.